Differences in treatment and survival rates of non-small-cell lung cancer in three regions of France
Open Access
- 1 November 1995
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 72 (5) , 1278-1282
- https://doi.org/10.1038/bjc.1995.500
Abstract
Treatment and survival rates of patients with non-small-cell lung cancer (NSCLC) were compared between three French Cancer Registries (Calvados, Doubs, Tarn). The methodological issues in such comparisons are discussed. The treatments for NSCLC differed between the regions: radiotherapy tended to be preferred in Calvados (73% vs 21.3% surgery), whereas surgery was more frequently employed in Doubs and Tarn (27.7% and 37% respectively). The percentage of cases receiving no therapeutic treatment ranged from 7.8% (Calvados) to 26% (Tarn). Despite the differences in treatment, the overall survival rates were similar in the three regions. Adjustment for treatment in such a descriptive study may be misleading since different therapeutic strategies in different regions may lead to selection of patients of systematically better or poorer prognosis in the various treatment groups.Keywords
This publication has 11 references indexed in Scilit:
- The reliability of Cancer Registry recordsBritish Journal of Cancer, 1993
- Does cancer survival differ for older patients?Cancer, 1992
- Survival for lung cancer in northern ItalyCancer Causes & Control, 1992
- Men, women and primary lung cancer —A Saskatchewan personal interview studyJournal of Clinical Epidemiology, 1991
- Chemotherapy in advanced non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Time trends in the outcome of lung cancer management: a study of 9,090 cases diagnosed in the Mersey Region, 1974-86British Journal of Cancer, 1990
- [Pretherapeutic evaluation of primary bronchial cancer].1989
- Studying patterns of cancer care: how useful is the medical record?American Journal of Public Health, 1988
- Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.Journal of Clinical Oncology, 1988
- The Will Rogers PhenomenonNew England Journal of Medicine, 1985